Which Bioinformatics Tools You Need for Your Own Data
A working list of the tools that matter for analyzing your own genome, transcriptome, proteome, and biomarker data, with formats, flags, and the failure modes that bite.
A working list of the tools that matter for analyzing your own genome, transcriptome, proteome, and biomarker data, with formats, flags, and the failure modes that bite.
What fasting, post-meal, and 24-hour continuous glucose numbers look like in people without diabetes, what the reference data say, and how to analyze your own CGM export.
A working pipeline for whole-exome data from FASTQ to VCF, with the filters that matter and the places where exome capture loses to a whole genome.
What whole exome sequencing covers, where capture fails, and how to check the quality of an exome you already own.
A working pipeline from a counts matrix to a ranked, deduplicated pathway table for personal RNA-seq, including the n=1 designs that are valid, the blood cell composition problem, and which tools to trust.
How FDA assigns devices to class I, II or III under 21 CFR Part 860, covering classification regulations, De Novo requests and 510(k) exemptions.
A practical guide to comparing whole genomes: your VCF against the reference, two callsets of the same sample, your genome against a relative's, and human against other species. Tools, flags, and the failure modes that produce fake differences.
What pharmacogenomic panels like GeneSight measure, what the trial data show, how to read CYP2D6 and CYP2C19 from your own genome, and what serum drug levels can and cannot tell you.
What the five ACMG tiers mean on a BRCA report, how to pull the same calls from your own VCF, and what short-read sequencing misses.
What CGM error looks like in the data: interstitial lag, compression artifacts, sensor-to-sensor bias, and a protocol for measuring your own sensor's accuracy against fingersticks using the raw exports.
What China's commercial health insurance innovative drug list is, which drugs may apply to it, and what a place on the list gives.
What whole-genome screening in a healthy adult finds, what it misses, which files and tools to use, and where the interpretation gets hard enough that you need a clinician.
List prices for SomaScan 7K and 11K at core facilities run $800–900 per sample before shipping, plate minimums, and analysis. Here is where that money goes, how the assay works, and how to decide between SomaScan, Olink Reveal, and a targeted panel.
A working pipeline that turns 30x whole-genome FASTQ or CRAM into a filtered and annotated variant call set, with the tools and checks we would use.
A practical walkthrough from FASTQ to gene-level counts, cell-composition estimates, and pathway scores, written for someone analyzing their own blood RNA-seq rather than a two-group experiment.
A technical comparison of array-based consumer DNA tests, consumer whole-genome sequencing, and clinician-ordered panels: file formats, error modes, prices, and what to do with the raw data.
A price breakdown of array genotyping, panels, exomes, and whole genomes, what each price includes, and what you get back as files.
Mean platelet volume is a derived number from a fitted histogram, and it drifts with tube age and analyzer model. Here is how to tell a real low MPV from a preanalytical artifact, and what to measure alongside it.
How to get pharmacogenomic (PGx) results at home, why sequencing beats the saliva-kit panels for most genes, and how to run PharmCAT, Aldy, and HLA typing over your own data without over-reading the output.
A practical guide to designing, quantifying, and modeling a longitudinal RNA-seq series from one person — sampling schedule, salmon quantification, spline and impulse models, trajectory clustering, and the confounders that will ruin the result if you ignore them.